Prosecution Insights
Last updated: August 06, 2026
Application No. 18/832,519

METHOD FOR PREPARING OAT-BASED CONDIMENTS

Non-Final OA §103§112
Filed
Jul 24, 2024
Priority
Jan 24, 2022 — FI 20225052 +1 more
Examiner
DUBOIS, PHILIP A
Art Unit
Tech Center
Assignee
OY Karl Fazer AB
OA Round
1 (Non-Final)
25%
Grant Probability
At Risk
1-2
OA Rounds
2y 7m
Est. Remaining
50%
With Interview

Examiner Intelligence

Grants only 25% of cases
25%
Career Allowance Rate
131 granted / 527 resolved
-35.1% vs TC avg
Strong +25% interview lift
Without
With
+24.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 8m
Avg Prosecution
43 currently pending
Career history
600
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
60.7%
+20.7% vs TC avg
§102
8.4%
-31.6% vs TC avg
§112
24.1%
-15.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 527 resolved cases

Office Action

§103 §112
DETAILED ACTION Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-19 and 21 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 is rejected for reciting the term glutaminase (E.C. 3.5.1.2). It is not clear whether the information in the parentheses is a preference or required classification. Claim 1 is also rejected as it is in unclear what percentages refence in steps a) and b) (e.g., weight). It is also unclear what the dry matter is based on (e.g., oat raw material). Claims 2-19 and 21 are rejected for being dependent on or relying on claim 1. Claims 5-7 are also rejected as they also reference a percentage of material based on dry matter. It is also unclear what the percentage (e.g., weight) and dry matter is based on (e.g., oat raw material). Claim 8 is also rejected as claim 8 recites that the oat raw material is an aqueous oat suspension treated with amylases. However, step b) of claim 1 recites that the aqueous oat suspension is prepared from the oat raw material. It is unclear what needs to be done in claim 8 in terms of the raw material and aqueous suspension so as to satisfy both step b) of claim 1 and also claim 8. As to claim 10, the terms “wet form” and “dry form” are in parentheses. It is not clear whether the information in the parentheses is a preference or required. Claim 10 is also rejected as it is recited that the aqueous oat suspension is obtained by adjusting the dry matter. However, step b) of claim 1 recites that the aqueous oat suspension is prepared from the oat raw material. It is unclear what needs to be done in step b) of claim 1 and claim 10 in terms of the raw material and aqueous suspension so as to satisfy step b) of claim 1 as well as claim 10. Claim 19 is rejected for reciting “using” the liquid and solid product. It is unclear how they are being used (i.e., as an ingredient for a sauce or paste, respectively, or some intermediate product). Claim 19 is also rejected for reciting “miso-like”. The term “miso-like” in claim 19 is a relative term which renders the claim indefinite. The term “miso-like” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 21 is/are rejected under 35 U.S.C. 103 as being unpatentable over WO 02/01963 (VADEHRA) (See IDS of 10/23/2024) in view of CN112438365. A translation for CN112438365 is provided with this Official Action. PNG media_image1.png 74 679 media_image1.png Greyscale As to claim 21, VADEHRA teaches a process for making an vegetable protein based seasoning/condiment (pg. 1, lines 5-10). VADEHERA teaches treating vegetable protein with exopeptidases, endopeptidase and glutaminases (pg. 4, lines 15-25). Step g) is taught at pg. 7, lines 15-20, wherein the enzyme is inactivated. Step h) is taught at pg. 7, lines 15-20 where is taught that the obtained product can be recovered by centrifugation. This would naturally result in a separation based on liquid and solid. As to the pH, VADEHRA teaches that the pH can be selected based on the optimum pH of the enzyme used (e.g., 5-7.5) at pg. 7, lines 1-3. VADHERA does not teach that the vegetable protein can be oat protein. CN112438365 teaches providing an oat raw material (lines 34-40). The result is a plant protein hydrolysate (lines 14-15) and the process has advantages in terms of refining time, energy consumption, enzymatic hydrolysis time, concentration time, artificial use, and final taste performance of the product, and has achieved beneficial technical effects. Thus, it would have been obvious to one skilled in the art to use the oat protein product of CN112438365 in VADHERA, as CN112438365 teaches an improved plant protein product and process of obtaining the product. Claim(s) 21 is/are rejected under 35 U.S.C. 103 as being unpatentable over United States Patent Application Publication No US20150351432A1 (Triantafyllou ). PNG media_image1.png 74 679 media_image1.png Greyscale Claim 21 is directed to an oat food additive/condiment that can be wet-milled and have a pH of 4.0 to 6.7 [0047], a starch content less than 5% and a protein content of at least 24%. Triantafyllou discloses a wet-milled product with a solids content of 8-13%, a pH of 6.6, a protein content of at least 20% [0026]. The overall amount of starch is not taught. However, it is taught to degrade the starch [0026]. It would have been obvious to eliminate starch. The oat-based product is treated with glutaminase [0036] and the claimed product is silent as to the exact nature of the peptide/protein content. Claims Free of Prior Art Claims 1-19 are free of prior art. US20150351432A1 (Triantafyllou ) teaches a method for preparing an oat-based condiment/food additive [0001] by treating the oat-based condiment with glutaminase [0036]. However, Triantafyllou avoids treating the material with exo- and endo-peptidases [0029]. CN112438365 (a translation is also provided) teaches providing an oat raw material (lines 34-40) but does not teach a raw material with the same protein, starch or beta-glucan content or treating the material with exo- and endo-peptidases. United States Patent No. 6,036,983 (see IDS of 10/23/2024) does teach a process that treats an oat material with glutaminase, exopeptidases and endo peptidases but does not teach a raw oat material as claimed or treating the raw oat material to obtain the claimed amounts of protein and starch. There is also no recognition of treating the oat material with homogenization, wet milling or micro-fluidization. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILIP A DUBOIS whose telephone number is (571)272-6107. The examiner can normally be reached M-F, 9:30-6:00p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nikki Dees can be reached at 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHILIP A DUBOIS/ Examiner, Art Unit 1791 /Nikki H. Dees/ Supervisory Patent Examiner, Art Unit 1791
Read full office action

Prosecution Timeline

Jul 24, 2024
Application Filed
Jul 14, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12628840
GROUP OF MICROORGANISMS COMPOSED BY LACTOBACILLUS SP STRAIN K03D08, BACILLUS SP STRAIN K03B01 AND KAZACHSTANIA SP STRAIN K03K02G AND ITS COMPOSITIONS; A PROCESS FOR OBTAINING CASEIN-FREE DAIRY DERIVATIVE CONTAINING SHORT-CHAIN FATTY ACIDS AND HYDROXYLATED SHORT-CHAIN FATTY ACIDS GENERATED BY THE METABOLISM OF THE GROUP OF MICROORGANISMS
3y 8m to grant Granted May 19, 2026
Patent 12618028
FERMENTED AND ESTERIFIED MOLASSES
3y 1m to grant Granted May 05, 2026
Patent 12599154
BEVERAGE
8y 12m to grant Granted Apr 14, 2026
Patent 12600930
Process for Aging Distilled Spirits
4y 10m to grant Granted Apr 14, 2026
Patent 12543755
COMPOSITION COMPRISING AN OIL PHASE
7y 10m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
25%
Grant Probability
50%
With Interview (+24.6%)
4y 8m (~2y 7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 527 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month